Centene Corporation CNC

61.82 (0.10) (0.16%) as of 25 Sep
Market cap
$30.6B
P/E
0.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Centene Corporation (CNC) EV/EBITDA

Centene Corporation has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (September 2026) to 22.5× (April 2020) — the current reading is the lowest in ten years.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 7.6× (19.85%)
FY2023 9.5× (47.51%)
FY2022 18.0× 7.60%
FY2021 16.7× 87.95%
FY2020 8.9× (19.26%)
FY2019 11.0× (6.83%)
FY2018 11.8× 3.83%
FY2017 11.4× 84.45%
FY2016 6.2× (25.90%)

Quarterly

Period EV/EBITDA Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 22.5×
Ten-year median 9.4×
Current reading's percentile 8

EV/EBITDA against peers

Company EV/EBITDA
CLOV Clover Health Investments, Corp. compare n/m
CNC Centene Corporation n/m
CI Cigna Group compare 7.7×
OSCR Oscar Health, Inc. compare 8.4×
CVS CVS Health Corporation compare 8.7×
ELV Elevance Health, Inc. compare 9.0×
HUM Humana Inc. compare 10.9×
MOH Molina Healthcare, Inc compare 13.0×
UNH UnitedHealth Group Incorporated compare 14.5×
Healthcare Plans industry median 10.9×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on CNC